Sunitinib

Papers on sunitinib

12 papers1 new in 30 days

Saturday, November 7

Friday, October 16

Tuesday, October 6

Biomedicine & Pharmacotherapy

Sunitinib selectively killed senescent cells in the lab

A drug screen in human connective-tissue cells linked the selective killing effect to a protein that receives growth signals.A drug screen in human connective-tissue cells linked the selective killing effect to a protein that receives growth signals.

Figure from Biomedicine & Pharmacotherapy
Experiments in human cellsInterventions

Friday, August 28

Neurotherapeutics

Enzyme-blocking drugs linked to lower Parkinson disease risk

Among 11 drugs examined, sorafenib prescription fills were linked to a relative risk of 0.43 for Parkinson disease compared with no fills for that drug.Among 11 drugs examined, sorafenib prescription fills were linked to a relative risk of 0.43 for Parkinson disease compared with no fills for that drug.

Case-control studyParkinson's disease

Saturday, April 25

Wednesday, December 10

Tuesday, October 4

Tuesday, June 21

Saturday, September 26

Tuesday, November 6

Saturday, August 20

Tuesday, August 2